Chat with us
Research Assistance
Online
  • Please enter your first name.

China Metagenomics Market Size & Outlook, 2024-2030

The metagenomics market in China is expected to reach a projected revenue of US$ 244.2 million by 2030. A compound annual growth rate of 16.3% is expected of China metagenomics market from 2024 to 2030.

  • Biotechnology
    • Genomics & Genetic Engineering
      • Metagenomics Market Outlook
Revenue, 2023 (US$M)
$84.6
Forecast, 2030 (US$M)
$244.2
CAGR, 2024 - 2030
16.3%
Report Coverage
China
GVR research-powered AI

Ask Prism AI about the metagenomics market

Get cited answers from GVR research on market growth, segments, regulations and forecasts.

  • Source-linked answers
  • Market-specific context
  • Traceable figures
Explore Prism AI

China metagenomics market highlights

  • The China metagenomics market generated a revenue of USD 84.6 million in 2023 and is expected to reach USD 244.2 million by 2030.
  • The China market is expected to grow at a CAGR of 16.3% from 2024 to 2030.
  • In terms of segment, kits & reagents was the largest revenue generating product in 2023.
  • Sequencing & Data Analytics Services is the most lucrative product segment registering the fastest growth during the forecast period.


Metagenomics market data book summary

Market revenue in 2023USD 84.6 million
Market revenue in 2030USD 244.2 million
Growth rate16.3% (CAGR from 2023 to 2030)
Largest segmentKits & reagents
Fastest growing segmentSequencing & Data Analytics Services
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationKits & Reagents, Sequencing & Data Analytics Services, Software
Key market players worldwideBio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG


Other key industry trends

  • In terms of revenue, China accounted for 4.2% of the global metagenomics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China metagenomics market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 244.2 million by 2030.

China has one of the fastest growing and most advanced metagenomics markets. In 2020, the country’s genetic testing companies raised approximately USD 3 billion in financing. NGS can improve human health by enabling early diagnosis of rare diseases, more pathogen monitoring, and improved outcomes for cancer patients.

Each year, 4 million people in the country are diagnosed with cancer, accounting for nearly 30% of cancer-related deaths globally. Thus, NGS testing is the only way to meet the unmet needs of patients by offering personalized therapies. Furthermore, NGS has proven to be a powerful tool during the COVID-19 pandemic. These factors have fueled the demand for NGS in China.

No credit card required*

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study
Turnaround
5–10 working days

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Metagenomics Market Companies

NameProfile# EmployeesHQWebsite
Thermo Fisher Scientific IncView profile 122,000168 Third Avenue, Waltham, MA, United States, 02451www.thermofisher.com
Roche Holding AGView profile 103,605Grenzacherstrasse 124, Basel, Switzerland, 4070www.roche.com
Illumina IncView profile 9,3005200 Illumina Way, San Diego, CA, United States, 92122www.illumina.com
Bio-Rad Laboratories IncView profile 8,0301000 Alfred Nobel Drive, Hercules, CA, United States, 94547www.bio-rad.com
Qiagen NVView profile 5,900Hulsterweg 82, Venlo, LI, Netherlands, 5912 PLwww.qiagen.com
Takara Bio IncView profile 1,793Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058www.takara-bio.co.jp
PerkinElmerView profile 10001+Waltham, Massachusetts, United States, North Americawww.perkinelmer.com
NovogeneView profile 501-1000Beijing, Beijing, China, Asiaen.novogene.com/
PromegaView profile 5001-10000Madison, Wisconsin, United States, North Americawww.promega.com/es
Oxford Nanopore Technologies PLCView profile 1,133Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, United Kingdom, OX4 4DQwww.nanoporetech.com

China Metagenomics Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Metagenomics Market Outlook will help companies and investors design strategic landscapes.


Kits & Reagents was the largest segment with a revenue share of 61.47% in 2023.

Horizon Databook has segmented the China metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.




China has one of the fastest growing and most advanced metagenomics markets. In 2020, the country’s genetic testing companies raised approximately USD 3 billion in financing. NGS can improve human health by enabling early diagnosis of rare diseases, more pathogen monitoring, and improved outcomes for cancer patients.

Each year, 4 million people in the country are diagnosed with cancer, accounting for nearly 30% of cancer-related deaths globally. Thus, NGS testing is the only way to meet the unmet needs of patients by offering personalized therapies. Furthermore, NGS has proven to be a powerful tool during the COVID-19 pandemic. These factors have fueled the demand for NGS in China.

  • China Metagenomics Market Application Outlook (Revenue, USD Million , 2018-2030)
    • Others
    • Clinical Diagnostics
    • Drug Discovery
    • Biotechnology
    • Environmental
    • Food & nutrition
  • China Metagenomics Market Technology Outlook (Revenue, USD Million , 2018-2030)
    • Whole Genome Sequencing
    • Shotgun Sequencing
    • Others
    • 16S Sequencing
  • China Metagenomics Market Product Outlook (Revenue, USD Million , 2018-2030)
    • Sequencing & Data Analytics Services
    • Kits & Reagents
    • Software
  • China Metagenomics Market Workflow Outlook (Revenue, USD Million , 2018-2030)
    • Pre-sequencing
    • Sequencing
    • Data Analysis

Reasons to subscribe to Metagenomics Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Metagenomics Market Outlook databook

  • Our clientele includes a mix of Metagenomics Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China Metagenomics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Metagenomics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.

China Metagenomics Market, 2018-2030 (US$M)

No Access Stack Chart

China metagenomics market statistics, by application, 2018-2030 (US$M)

No Access Pie Chart

China metagenomics market statistics, by application, 2018-2030 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more